Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001822782-23-000003
Filing Date
2023-09-18
Accepted
2023-09-18 11:18:38
Documents
1
Effectiveness Date
2023-09-18
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6512
  Complete submission text file 0001822782-23-000003.txt   7648
Mailing Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-492316 | Film No.: 231260439